Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CLYM stock hub

Climb Bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CLYMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

543.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CLYM

In the news

Latest news · CLYM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-30.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CLYM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001768446
Company name	Climb Bio, Inc.
Country	United States
Country code	US
Cusip	28658R106
Employees	29
Employees Change	11%
Employees Change Percent	61.11
Enterprise value	$397.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-08-10
Isin	US28658R1068
Last refreshed	2026-05-10
Market cap	$543.1M
Market cap category	Small-Cap
Price	$11.37
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CLYM
Website	https://climbbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.72%
FCF yield	-9.85%
P/B ratio	3.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-52.8M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-1.8M
ROA	-21.27
Roa5y	-16.82
ROCE	-40.51
ROE	-30.92
Roe5y	-37.77
ROIC	-21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	841.11%
Cagr3y	49.67%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$152.4M
Cash	$109.6M
Current Assets	$113.4M
Current Liabilities	$4.1M
Debt	$479,000
Debt Equity	$0
Equity	$148.1M
Liabilities	$4.3M
Long Term Assets	$39M
Long Term Liabilities	$216,000
Net Cash	$145.8M
Net Cash By Market Cap	$26.85
Net Cash Growth	-26.12%
Net Debt Equity	$-0.98
Tangible Book Value	$148.1M
Tangible Book Value Per Share	$3.1
WACC	4.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	27.86
Net Working Capital	$32,000
Quick ratio	26.91
Working Capital	$109.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	839.67%
200-day SMA	4.23
3Y total return	235.4%
50-day SMA	8.08
50-day SMA vs 200-day SMA	50over200
All Time High	29.69
All Time High Change	-61.7%
All Time High Date	2021-08-30
All Time Low	1.05
All Time Low Change	982.86%
All Time Low Date	2025-04-07
ATR	0.83
Beta	0.03
Beta1y	1.92
Beta2y	1.54
Ch YTD	184.3
High	12.24
High52	12.48
High52 Date	2026-05-07
High52ch	-8.89%
Low	11.32
Low52	1.13
Low52 Date	2025-05-15
Low52ch	906.2%
Ma50ch	40.68%
Premarket Change Percent	1.34
Premarket Price	$12.07
Price vs 200-day SMA	169.05%
RSI	69.24
RSI Monthly	74.27
RSI Weekly	79.43
Sharpe ratio	2.71x
Sortino ratio	5.37
Total Return	-15.07%
Tr YTD	184.3
Tr1m	65.5%
Tr1w	27.61%
Tr3m	109.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	7
Analyst Price Target Top	$19.57
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.3
Operating Income	$-60.1M
Price target	$18.42
Price Target Change	$62.01
Price Target Change Top	$72.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,063,410%
Float Percent	58.75%
Shares Insiders	1.1%
Shares Institutions	35.37%
Shares Out	47,768,543
Shares Qo Q	1.24%
Shares Yo Y	15.07%
Short Float	5.74%
Short Ratio	3.29
Short Shares	3.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-61.1M
Average Volume	968,681.45x
Bv Per Share	3.1
CAPEX	$-186,000
Ch1m	65.5
Ch1w	27.61
Ch1y	839.7
Ch3m	109
Ch3y	235.4
Ch6m	521.3
Change	-4.53%
Change From Open	-4.53
Close	11.91
Days Gap	0
Depreciation Amortization	135,000
Dollar Volume	12,954,557.3
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-60.1M
EPS	$-0.79
F Score	1
FCF	$-53.5M
FCF EV Yield	-13.46x
FCF Per Share	$-1.12
Financing CF	-16,000
Fiscal Year End	December
Founded	2,018
Investing CF	32,629,000
Iprfo	-30.03
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	4.96
Ma150ch	129.19%
Ma20	9.59
Ma20ch	18.51%
Net CF	-20,664,000
Next Earnings Date	2026-08-11
Open	11.91
Optionable	Yes
Position In Range	5.43
Post Close	11.37
Postmarket Change Percent	3.25
Postmarket Price	$11.74
Ppne	697,000
Pre Close	11.91
Price Date	2026-05-08
Ptbv Ratio	3.67
Relative Volume	1.18x
Share Based Comp	7,637,000
Tr6m	521.31%
Us State	Massachusetts
Volume	1,139,363

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CLYM pay a dividend?

Capital-return profile for this ticker.

Performance

CLYM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CLYM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.4%

Float: +58.7% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CLYM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.2

Neutral momentum band

Price vs 200-day MA

+169.0%

50/200-day relationship not available

Beta (5Y)

0.03

Less volatile than the market

Sharpe ratio

2.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CLYM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CLYM stock rating?

Climb Bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CLYM analysis?

The full report lives at /stocks/CLYM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CLYM?

The latest report frames CLYM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CLYM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.